Key Takeaways
- The S&P 500 slipped 0.8% on Tuesday, May 6, 2025, falling for a second straight day as investors awaited news on U.S. tariff policies and prepare dfor tomorrow’s Federal Reserve announcement.
- Moderna and Vertex Pharmaceuticals shares plunged after pausing a cystic fibrosis clinic trial, while drugmakers also declined on the FDA’s appointment of a new top vaccine regulator.
- Constellation Energy jumped on a strong earnings report elevated by continued strong power demand for AI facilities.
The S&P 500 dropped for a second straight session as investors digested corporate earnings reports, waited for tariff updates and readied themselves for tomorrow’s Federal Reserve’s announcement on interest rates.
The 澳洲幸运5官方开奖结果体彩网:S&P 500 fell 0.8% on Tuesday, while the 澳洲幸运5官方开奖结果体彩网:Dow Jones Industrial Average slipped by about 1% and the Nasdaq was lower by 0.9%. The results marked a second straight day of declines for stocks after a run of nine consecutive winning sessions for the S&P 500 and Dow. Read today's full markets coverage here.
Palantir’s (PLTR) stock dropped by 12%. The AI software firm 澳洲幸𒁏运5官方开奖结果体彩♔网:didn’t deliver strong enough earnings to impress investors after it reported adjusted earnings per share that were in line with analysts' expectations. The company reported a batter-than-expected 39% jump in quarterly revenue and raised its full-year outlook on growing demand for its AI software. 澳洲幸运5官方开奖结果体彩网:Analysts raised questions about its valuation, as the stock price was up over 40% for 2025 and ꦆ4꧋00% over the past 12 months.
Vertex Pharmaceuticals (VRTX) was down 10% after it paused a cystic fibrosis clinic trial it was conducting with Moderna (MRNA). The delayed trial at Vertex was part of a series of costs that led to 澳洲幸运5官方💜开奖结果体彩网:wo♌rse-than-expected quarterly earnings.
Pharmaceutical stocks were also weighed down by news that the Food and Drug Administration named Dr. Vinay Prasad, a critic of the U.S. Covid-19 response, as its top vaccine regulator. Regeneron Pharmaceutical (REGN) was down more than 7%, while Eli Lilly (LLY) sank almost 6% and Bristol-Myers Squibb (BMY) was down 5%. Moderna was down around 12%.
DoorDash (DASH) stock dropped by more than 7% after it moved up its scheduled earnings result release to this morning, with the fo❀od delivery service🥃 reporting underwhelming revenue for the quarter. The company said it was buying U.K. firm Deliveroo for 澳洲幸运5官方开奖结果体彩网:nearly $4 billion and restaurant booking pla🍸tform SevenRooms for $1.2ಞ billion.
Constellation Energy (CEG) shares rose 10% to deliver the best performance in the S&P 500 after the nuclear energy provider continued to benefit from 澳洲幸运5官方开奖结果体彩网:artificial intelligence-driven electricity demand. It 澳洲幸运5官方开奖结果体彩网:beat its quarterly operat♏ing revenue forecasts and maintained its 2025 outlook, even though its profits were weaker than expected. The company also said its $26.6 billion purchase of natural gas and geothermal 澳洲幸运5官方开奖结果体彩网:energy firm Calpine is on track to beꦦ completed by the end of the year.
Engineering firm Leidos Holdings (LDOS) was 4.6% higher after its better-than-expected results indicated that the company may not see too much earnings loss from cuts to government spending from programs like the Departmen♈t of Gover🦄nment Efficiency.
Ford Motor (F) shares climbed by 2.7% after it reported quarterly earnings that beat analysts’ expectations but 澳洲幸运5官方开奖结果体彩网:suspended its full-year outlook amid uncertainty about tariffs. Super Micro Computer (SMCI) was up by 2.4% ahead of its earningꦐs report, due after markets closed.